NKTX
Nkarta Inc
Price:  
2.41 
USD
Volume:  
572,710.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NKTX Relative Valuation

-1586.5%
Upside

As of 2026-03-12, the Relative Valuation of Nkarta Inc (NKTX) is (35.90) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.41 USD, the upside of Nkarta Inc based on Relative Valuation is -1586.5%.

The range of the Relative Valuation is (32.19) - (41.92) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 22.3x - 30.4x 26.2x
Forward P/E multiples 22.1x - 29.0x 23.5x
Fair Price (32.19) - (41.92) (35.90)
Upside -1432.7% - -1835.9% -1586.5%
2.41 USD
Stock Price
(35.90) USD
Fair Price

NKTX Relative Valuation - Historical P/E Data

Date P/E
2026-03-05 -1.70
2026-03-04 -1.89
2026-03-03 -1.78
2026-03-02 -1.87
2026-02-27 -1.87
2026-02-26 -1.81
2026-02-25 -1.79
2026-02-24 -1.74
2026-02-23 -1.60
2026-02-20 -1.61
2026-02-19 -1.63
2026-02-18 -1.54
2026-02-17 -1.43
2026-02-13 -1.36
2026-02-12 -1.36
2026-02-11 -1.38
2026-02-10 -1.38
2026-02-09 -1.39
2026-02-06 -1.40
2026-02-05 -1.33
2026-02-04 -1.42
2026-02-03 -1.54
2026-02-02 -1.50
2026-01-30 -1.54
2026-01-29 -1.68
2026-01-28 -1.71
2026-01-27 -1.76
2026-01-26 -1.70
2026-01-23 -1.72
2026-01-22 -1.66
2026-01-21 -1.52
2026-01-20 -1.41
2026-01-16 -1.41
2026-01-15 -1.36
2026-01-14 -1.43
2026-01-13 -1.42
2026-01-12 -1.51
2026-01-09 -1.45
2026-01-08 -1.46
2026-01-07 -1.43
2026-01-06 -1.34
2026-01-05 -1.32
2026-01-02 -1.29
2025-12-31 -1.28
2025-12-30 -1.27
2025-12-29 -1.28
2025-12-26 -1.27
2025-12-24 -1.25
2025-12-23 -1.25
2025-12-22 -1.25